BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 27435907)

  • 1. Thiocyanate Accumulation in Critically Ill Patients Receiving Nitroprusside Infusions.
    Morris AA; Page RL; Baumgartner LJ; Mueller SW; MacLaren R; Fish DN; Kiser TH
    J Intensive Care Med; 2017 Oct; 32(9):547-553. PubMed ID: 27435907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective study of sodium nitroprusside use and assessment of the potential risk of cyanide poisoning.
    Johanning RJ; Zaske DE; Tschida SJ; Johnson SV; Hoey LL; Vance-Bryan K
    Pharmacotherapy; 1995; 15(6):773-7. PubMed ID: 8602386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium nitroprusside-induced cyanide intoxication and prevention with sodium thiosulfate prophylaxis.
    Hall VA; Guest JM
    Am J Crit Care; 1992 Sep; 1(2):19-25; quiz 26-7. PubMed ID: 1307887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of sodium nitroprusside alone and in combination with sodium thiosulfate on the acid-base balance, and on thiocyanate and iron plasma levels in the rabbit.
    Höbel M; Kreye VA; Pill J
    Klin Wochenschr; 1978; 56 Suppl 1():147-52. PubMed ID: 732247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of fetal and maternal cyanide toxicity from nitroprusside with coinfusion of sodium thiosulfate in gravid ewes.
    Curry SC; Carlton MW; Raschke RA
    Anesth Analg; 1997 May; 84(5):1121-6. PubMed ID: 9141943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antidotal action of thiosulfate following acute nitroprusside infusion in dogs.
    Vesey CJ; Krapez JR; Varley JG; Cole PV
    Anesthesiology; 1985 Apr; 62(4):415-21. PubMed ID: 2984962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of sodium nitroprusside toxicity in pediatric cardiac surgical patients.
    Moffett BS; Price JF
    Ann Pharmacother; 2008 Nov; 42(11):1600-4. PubMed ID: 18957627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium-nitroprusside-induced cyanide toxicity in pediatric patients.
    Thomas C; Svehla L; Moffett BS
    Expert Opin Drug Saf; 2009 Sep; 8(5):599-602. PubMed ID: 19645589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring cyanide and thiocyanate concentrations during infusion of sodium nitroprusside in children.
    Linakis JG; Lacouture PG; Woolf A
    Pediatr Cardiol; 1991 Oct; 12(4):214-8. PubMed ID: 1946009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium thiosulphate decreases blood cyanide concentrations after the infusion of sodium nitroprusside.
    Cole PV; Vesey CJ
    Br J Anaesth; 1987 May; 59(5):531-5. PubMed ID: 3580232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propylene glycol accumulation in critically ill patients receiving continuous intravenous lorazepam infusions.
    Horinek EL; Kiser TH; Fish DN; MacLaren R
    Ann Pharmacother; 2009 Dec; 43(12):1964-71. PubMed ID: 19920159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cyanide antidotes used with sodium nitroprusside infusions: sodium thiosulphate and hydroxocobalamin given prophylactically to dogs.
    Krapez JR; Vesey CJ; Adams L; Cole PV
    Br J Anaesth; 1981 Aug; 53(8):793-804. PubMed ID: 7272142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyanide toxicity of sodium nitroprusside in therapeutic use with and without sodium thiosulphate.
    Schulz V; Gross R; Pasch T; Busse J; Loeschcke G
    Klin Wochenschr; 1982 Nov; 60(22):1393-400. PubMed ID: 7176461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thiocyanate toxicity arising from prolonged use of sodium nitroprusside in severe heart failure].
    Lage SG; Carvalho RT; Kopel L; Monachini MC; Bellotti G; Pileggi F
    Arq Bras Cardiol; 1994 Mar; 62(3):155-7. PubMed ID: 7980075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of intraventricular sodium nitroprusside and thiosulfate for the treatment of cerebral vasospasm in the intensive care unit setting.
    Thomas JE; McGinnis G
    Stroke; 2002 Feb; 33(2):486-92. PubMed ID: 11823657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined antidotal and hemodialysis treatments for nitroprusside-induced cyanide toxicity.
    Marbury TC; Sheppard JE; Gibbons K; Lee CS
    J Toxicol Clin Toxicol; 1982 Jul; 19(5):475-82. PubMed ID: 7175992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of sodium nitroprusside during prolonged infusion in pediatric patients.
    Hammer GB; Lewandowski A; Drover DR; Rosen DA; Cohane C; Anand R; Mitchell J; Reece T; Schulman SR
    Pediatr Crit Care Med; 2015 Jun; 16(5):397-403. PubMed ID: 25715047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyanide and thiocyanate concentrations following sodium nitroprusside infusion in man.
    Vesey CJ; Cole PV; Simpson PJ
    Br J Anaesth; 1976 Jul; 48(7):651-60. PubMed ID: 797397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of vitamin B12 in the treatment and prevention of nitroprusside-induced cyanide toxicity.
    Zerbe NF; Wagner BK
    Crit Care Med; 1993 Mar; 21(3):465-7. PubMed ID: 8440119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dialysis for thiocyanate intoxication: a case report and review of the literature.
    Nessim SJ; Richardson RM
    ASAIO J; 2006; 52(4):479-81. PubMed ID: 16883131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.